Avenue Therapeutics Inc (ATXI)

NASDAQ
4.21
-0.15(-3.44%)
  • Volume:
    180,530
  • Bid/Ask:
    4.22/4.37
  • Day's Range:
    4.17 - 4.46

ATXI Overview

Prev. Close
4.36
Day's Range
4.17-4.46
Revenue
-
Open
4.4
52 wk Range
2.85-12.34
EPS
-0.3
Volume
180,530
Market Cap
70.51M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
297,692
P/E Ratio
-
Beta
0.68
1-Year Change
-59.67%
Shares Outstanding
16,748,068
Next Earnings Date
Aug 19, 2021
What is your sentiment on Avenue Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Avenue Therapeutics Inc News

Avenue Therapeutics Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell

Avenue Therapeutics Inc Company Profile

Avenue Therapeutics Inc Company Profile

Employees
4

Avenue Therapeutics, Inc. is a pharmaceutical company. The Company is focused on developing and commercializing its product principally for use in the acute/intensive care hospital setting. The Company’s product candidate is intravenous (IV) Tramadol, for the treatment of moderate to moderately severe post-operative pain. Tramadol, a synthetic dual-acting opioid, is a centrally acting analgesic with weak opioid agonist properties. It also works via the inhibition of serotonin and noradrenaline re-uptake and blocking nociceptive impulses at the spinal level. Its Oral tramadol is marketed in the United States for moderate to moderately severe pain in adults. Its Parenteral tramadol formulations include IV, intramuscular (IM), and subcutaneous (SC) formulations. Tramadol is marketed in the United States under the trade name Ultram immediate release tablet. Ultracet is a combination product containing tramadol and acetaminophen, is also marketed in the United States.

Read More
  • fingers crossed guys , good luck to you
    0
    • 12th April.. FDA is going to give the green light
      0
      • buyyy
        0
        • why?
          0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.